Have an account?
Log in to check out faster.
Loading...
May, 2024
June, 2024
Learn why you should start your probiotics journey with Bio-K+
Our scientifically proven formulas are designed to support your unique health journey
Probiotics heart health research reveals a fascinating link between gut bacteria and the cardiovascular system. Known as the gut-heart axis, this bidirectional pathway explains why Bio-K+, with more than 30 years of probiotic science, developed Heart Health Capsules featuring Limosilactobacillus reuteri NCIMB 30242 LRC™.
The gut and the heart are connected through a bidirectional signaling network. Gut microbes produce metabolites, including short-chain fatty acids and bile acids, that enter circulation and influence cardiovascular markers. An imbalanced gut microbiome can shift this dynamic in ways that matter for cardiovascular health. Probiotics for heart health are studied within this framework, as specific strains may help maintain a balanced microbiome. The gut-heart axis is an active and growing area of peer-reviewed research.
Cardiovascular probiotics work through three main mechanism families. First, short-chain fatty acid production, SCFAs generated by gut bacteria, has been linked to cardiovascular markers in meta-analyses of randomized trials. Second, bile acid recycling, which influences cholesterol metabolism. Third, immune and inflammation modulation, where a balanced microbiome may support healthy inflammatory responses. Effects are strain-specific and generally modest. Probiotics may support cardiovascular health as part of a daily wellness routine, complementary to diet, exercise, and medical care.* *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Systematic reviews examining probiotics and heart health markers point to modest, strain-dependent effects across three main areas. Cholesterol parameters remain the most studied. Blood pressure shows small but consistent signals in some meta-analyses. Research also points to hs-CRP, a recognized marker of cardiovascular health, as an area of active study.* The evidence on probiotics and heart health continues to grow, though effects vary by strain, dose, and individual. No probiotic is a substitute for diet, exercise, or prescribed cardiovascular medication. *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Bio-K+ has been studying probiotic science for more than 30 years, backed by 16 published clinical trials and 45+ peer-reviewed publications. The Bio-K+ heart health probiotic, Heart Health Capsules, features Limosilactobacillus reuteri NCIMB 30242 LRC™, selected specifically for bile salt hydrolase activity and cardiovascular research relevance. Delivered via delayed-release technology with CFU guaranteed until the best before or expiry date, it is also the number one pharmacist-recommended probiotic brand.* *2022 Survey on OTC Counselling and Recommendations: Pharmacy Practice + Business.
Not all probiotics do the same thing. Probiotic effects are strain-specific; genus, species, and strain code each matter. For those researching the best probiotics for heart health, the critical step is finding strains with published human clinical trials on cardiovascular markers. Limosilactobacillus reuteri NCIMB 30242 LRC™ is that strain, featured in Bio-K+ Heart Health Capsules. Choosing probiotics for heart health at the strain level, not the category level, is supported by the evidence.
Prebiotics are dietary fibers that feed beneficial gut bacteria. A synbiotic combines a probiotic with a prebiotic to amplify gut microbiome diversity. Recent research suggests that probiotic and prebiotic combinations may support gut-heart axis benefits more effectively than probiotics alone. Combining a daily probiotic with prebiotic-rich foods, fiber, polyphenols, and fermented vegetables represents the most evidence-supported lifestyle approach for microbiome-based cardiovascular support. Your healthcare provider can help you build a plan tailored to your cardiovascular wellness goals.
Probiotics are not a treatment for any cardiovascular disease. They are not a substitute for prescribed statins, antihypertensives, or other cardiovascular medications. Diet, physical activity, quality sleep, and stress management remain the core foundations of heart health. Probiotics heart health research supports a daily routine, complementary role within a broader lifestyle plan, not a replacement for medical care. Always speak to a healthcare provider before adjusting any prescribed medication.
The gut-heart axis describes the bidirectional signaling between the gut microbiome and the cardiovascular system. Gut bacteria produce metabolites, short-chain fatty acids, bile acids, and others that enter circulation and influence cardiovascular markers. Research into gut-heart axis probiotics is growing, with studies showing that specific strains may help maintain a balanced microbiome in ways that support this pathway. Probiotics may support, not treat or prevent, cardiovascular outcomes.
Probiotics cannot treat, cure, or prevent heart disease. What probiotics and heart health research shows is that specific strains may support cardiovascular markers already in the normal range. Most evidence centers on cholesterol parameters; blood pressure and inflammation markers are emerging areas. Effects are strain-specific and modest. Probiotics are best framed as a daily routine complement to diet and lifestyle. Always consult a healthcare provider. These statements have not been evaluated by the Food and Drug Administration.
Several strains appear in cardiovascular probiotics research. Limosilactobacillus reuteri NCIMB 30242 LRC™ is among the most-studied for cholesterol parameters, selected for bile salt hydrolase activity. Certain Lactiplantibacillus plantarum strains, CECT 7527, 7528, and 7529, have been examined for lipid profiles. Bifidobacterium lactis HN019 has been studied in metabolic syndrome populations. Bio-K+ Heart Health Capsules feature Limosilactobacillus reuteri NCIMB 30242 LRC™ as their primary cardiovascular strain.
Daily probiotics use general gut-support strains for digestive balance. The best probiotic for heart health uses strains specifically researched for cardiovascular markers, a meaningfully different selection criterion. Bio-K+ Original line drinkables target digestive and flora health. Bio-K+ Heart Health Capsules feature Limosilactobacillus reuteri NCIMB 30242 LRC™, selected for bile salt hydrolase activity. The strain should match the health goal. See the Heart Health Buying Guide for a full comparison.
Most clinical trials examining a heart-health probiotic and cardiovascular markers last 8 to 12 weeks. Consistency of daily intake matters far more than time of day. Track changes with your healthcare provider through standard cardiovascular markers, such as a cholesterol panel and blood pressure. Probiotics may support cardiovascular markers already in the healthy range, with gradual results best assessed alongside your healthcare provider over time. Always consult a healthcare provider before starting any supplement.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Follow @biokplususa and tag us to be mentioned
